Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
CELC - Celcuity Inc
-1.24(-7.52%)6:00:00 PM 11/26/2021
Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It develops CELsignia HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELsignia MP test to diagnose 11 cancer sub-types in breast, lung, colon, ovarian, kidney, and bladder cancers. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
PE Ratio
PEG Ratio-0.5
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %7%
Held by Institutions %25%
1 Day Vol Adjusted Return-1.6
1 Month Vol Adjusted Return-2.3
3 Month Vol Adjusted Return-7.8
6 Month Vol Adjusted Return-10.9
20 Days SMA Price ZScore-1.6
50 Days SMA Price ZScore-2.2
12 -26 Days PPO-4.3
1 Month Average Short Volume Ratio52.9
1 Day Volume Change ZScore-0.5
1 Month Daily Vol4.8
Related Topics
leak data

Related Topics


Related Peers

Stock news